RA Medical systems

Carlsbad, United States Founded: 2002 • Age: 24 yrs Listed
Excimer lasers for skin and vascular disease treatments are developed.

About RA Medical systems

RA Medical systems is a publicly listed company based in Carlsbad (United States) founded in 2002. Excimer lasers for skin and vascular disease treatments are developed. RA Medical systems has raised $24.29 million across 6 funding rounds from investors including Keiretsu Forum. The company has 14 employees. Its focus areas include Life Sciences, Dermatology, Medical Devices and Therapeutic Devices. Its legal entity is Ra Medical Systems, Inc. Its competitors include Avinger, LeMaitre Vascular and Okami Medical; 3 of its 3 listed competitors have raised funding.

Company details

Founded in 2002 and based in Carlsbad, United States, RA Medical Systems operates in the medical device sector. Xenon chloride excimer lasers are developed for treating skin conditions such as psoriasis, vitiligo, atopic dermatitis, and leukoderma, with the PHAROS EX-308 delivering 308 nm UVB rays. A DABRA system with disposable catheters is provided for minimally invasive endovascular procedures addressing vascular blockages.

  • Headquarters Carlsbad, United States
  • Employees 14
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website ramed.com
  • Social LinkedIn Facebook
  • Legal Name Ra Medical Systems, Inc.
Key Metrics
  • Total Equity Funding
    $24.29M (USD)

    in 6 rounds

  • Investors
  • Employee Count
    14

Funding Insights of RA Medical systems

RA Medical systems has successfully raised a total of $24.29M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $24.29M
  • Total Rounds 6
  • Investors Count 1

All 6 funding rounds of RA Medical systems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2023Post-IPO––
–
Aug 2022$6.22MPost-IPO––
–
Jun 2018$18.3MSeries A––
–
Sep 2017$650,000Series A––
–
Aug 2016$5.34MSeries A––
–
Jun 2011Seed––
Valuation history

1 investors in total: 1 institutional.

Investors in RA Medical systems

RA Medical systems has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Keiretsu Forum.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Accredited investors are networked for private equity funding opportunities.
2000keiretsuforum.comSan Francisco, United States
Premium access

Investor details for RA Medical systems

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of RA Medical systems

9 people are tracked at RA Medical systems (3 in leadership, 3 in board & advisors, 3 in team); the tracked headcount is 14.

NameRoleGroup
Will McGuire
CEO & DirectorLeadership
Ray Ramirez
IT DirectorLeadership
Bill Schmidt
Director of Laser Operations and FacilitiesLeadership
Richard Mejia, Jr.
DirectorBoard & advisors
James Caruso
DirectorBoard & advisors
David Jenkins
Executive ChairmanBoard & advisors
Al Memmolo
SVP, Clinical, Quality & Regulatory AffairsTeam
Brian D. Conn
Principal Financial Officer & Principal Accounting OfficerTeam
Joshio Torres, CPA
Senior AccountantTeam
Premium access

Complete people profiles for RA Medical systems

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of RA Medical systems

4 dated milestones of RA Medical systems across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded RA Medical systems is founded.
  2. Funding First funding round.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Post-IPO,.

Competitors of RA Medical systems

RA Medical systems has 3 listed competitors in our database, 3 of them funded. They include Avinger, LeMaitre Vascular and Okami Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
avinger.com2007Redwood, United States$170.85M80
Provider of image-guided catheter-based products for peripheral artery disease
lemaitre.com1983Burlington, United States$4.38M317
Devices for peripheral vascular disease treatment are developed and marketed.
okamimedical.com2011Aliso Viejo, United States$62.09M
Innovative medical devices for peripheral vessel treatment are developed.
Premium access

Detailed competitors of RA Medical systems

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Dermatology

3 companies that operate in the same segment as RA Medical systems (Dermatology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
2002Newark, New Jersey, United StatesUSD 154.56 MUSD 234.04 M597
Diagnostic tests for cancer prognosis are provided.
2008Friendswood, Texas, United StatesUSD 61.97 MUSD 344.23 M761
Adhesive patch biopsies for skin cancer detection are provided.
1996San Diego, California, United StatesUSD 24.37 MUSD 15.3 M259
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ra Medical Systems

Premium access

Complete news archive for RA Medical systems

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about RA Medical systems

RA Medical systems was founded in 2002 and raised its 1st funding round 9 years after it was founded.

RA Medical systems is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.

RA Medical systems is a funded company, having raised a total of $24.29M across 6 funding rounds to date.

RA Medical systems has 14 employees.

Founded in 2002 and based in Carlsbad, United States, RA Medical Systems operates in the medical device sector. Xenon chloride excimer lasers are developed for treating skin conditions such as psoriasis, vitiligo, atopic dermatitis, and leukoderma, with the PHAROS EX-308 delivering 308 nm UVB rays. A DABRA system with disposable catheters is provided for minimally invasive endovascular procedures addressing vascular blockages.

RA Medical systems's top competitors include Avinger, Okami Medical and LeMaitre Vascular.

RA Medical systems has 1 investor. Key investors include Keiretsu Forum.

RA Medical systems operates through Ra Medical Systems, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available